Clinical Trial Update: Image-based AI Predictive Biomarkers for Precision Neoadjuvant Triple-negative Breast Cancer Treatment

View source ↗

Summary

The clinical trial NCT05435352 evaluating image-based AI predictive biomarkers for precision neoadjuvant treatment in triple-negative breast cancer has been ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Snippet

Sponsor: Ourotech, Inc. | Conditions: Triple Negative Breast Cancer, Triple Negative Breast Neoplasms | Status: TERMINATED